Reaction
Meningoradiculitis reporting signals
As of the last recalculation, Meningoradiculitis appears in 108 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is IPILIMUMAB (PRR 83.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ipilimumab | 16 | 83.7 | 83.7 |
| Ixekizumab | 10 | 57.3 | 57.3 |